Photocure ASA reported Hexvix®/Cysview® revenues of NOK 105.9 million in the first quarter of 2023 and EBITDA of minus NOK 1.2 million.
Photocure ASA reported Hexvix®/Cysview® revenues of NOK 105.9 million in the first quarter of 2023 and EBITDA of minus NOK 1.2 million.